nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—ABCB1—lung cancer	0.217	1	CbGaD
Rivaroxaban—CYP3A5—Gefitinib—lung cancer	0.0388	0.0751	CbGbCtD
Rivaroxaban—CYP3A5—Teniposide—lung cancer	0.0376	0.0729	CbGbCtD
Rivaroxaban—ABCB1—Topotecan—lung cancer	0.0276	0.0535	CbGbCtD
Rivaroxaban—ABCB1—Gefitinib—lung cancer	0.0252	0.0489	CbGbCtD
Rivaroxaban—CYP3A5—Crizotinib—lung cancer	0.0238	0.0461	CbGbCtD
Rivaroxaban—CYP3A5—Erlotinib—lung cancer	0.0229	0.0444	CbGbCtD
Rivaroxaban—CYP3A5—Paclitaxel—lung cancer	0.021	0.0407	CbGbCtD
Rivaroxaban—CYP3A5—Irinotecan—lung cancer	0.0207	0.0401	CbGbCtD
Rivaroxaban—ABCB1—Vinorelbine—lung cancer	0.0194	0.0377	CbGbCtD
Rivaroxaban—CYP3A5—Etoposide—lung cancer	0.0166	0.0321	CbGbCtD
Rivaroxaban—CYP3A4—Topotecan—lung cancer	0.0165	0.032	CbGbCtD
Rivaroxaban—ABCB1—Crizotinib—lung cancer	0.0155	0.03	CbGbCtD
Rivaroxaban—CYP3A5—Docetaxel—lung cancer	0.0152	0.0294	CbGbCtD
Rivaroxaban—CYP3A4—Gefitinib—lung cancer	0.0151	0.0293	CbGbCtD
Rivaroxaban—ABCB1—Gemcitabine—lung cancer	0.0151	0.0293	CbGbCtD
Rivaroxaban—ABCB1—Erlotinib—lung cancer	0.0149	0.0289	CbGbCtD
Rivaroxaban—CYP3A4—Teniposide—lung cancer	0.0147	0.0284	CbGbCtD
Rivaroxaban—ABCB1—Paclitaxel—lung cancer	0.0137	0.0265	CbGbCtD
Rivaroxaban—ABCB1—Irinotecan—lung cancer	0.0135	0.0261	CbGbCtD
Rivaroxaban—ABCB1—Vinblastine—lung cancer	0.012	0.0232	CbGbCtD
Rivaroxaban—CYP3A4—Vinorelbine—lung cancer	0.0117	0.0226	CbGbCtD
Rivaroxaban—ABCB1—Cisplatin—lung cancer	0.011	0.0213	CbGbCtD
Rivaroxaban—ABCB1—Etoposide—lung cancer	0.0108	0.0209	CbGbCtD
Rivaroxaban—ABCB1—Docetaxel—lung cancer	0.00988	0.0191	CbGbCtD
Rivaroxaban—CYP3A4—Crizotinib—lung cancer	0.00927	0.018	CbGbCtD
Rivaroxaban—CYP3A4—Erlotinib—lung cancer	0.00894	0.0173	CbGbCtD
Rivaroxaban—CYP3A4—Paclitaxel—lung cancer	0.00819	0.0159	CbGbCtD
Rivaroxaban—CYP3A4—Irinotecan—lung cancer	0.00808	0.0156	CbGbCtD
Rivaroxaban—ABCB1—Doxorubicin—lung cancer	0.00736	0.0143	CbGbCtD
Rivaroxaban—CYP3A4—Vinblastine—lung cancer	0.00718	0.0139	CbGbCtD
Rivaroxaban—ABCB1—Methotrexate—lung cancer	0.00713	0.0138	CbGbCtD
Rivaroxaban—CYP3A4—Etoposide—lung cancer	0.00647	0.0125	CbGbCtD
Rivaroxaban—CYP3A4—Docetaxel—lung cancer	0.00592	0.0115	CbGbCtD
Rivaroxaban—CYP3A4—Doxorubicin—lung cancer	0.00441	0.00855	CbGbCtD
Rivaroxaban—F10—mammary gland—lung cancer	0.00222	0.233	CbGeAlD
Rivaroxaban—F10—cardiac atrium—lung cancer	0.00103	0.108	CbGeAlD
Rivaroxaban—CYP2J2—bronchus—lung cancer	0.000997	0.105	CbGeAlD
Rivaroxaban—CYP2J2—trachea—lung cancer	0.000895	0.0941	CbGeAlD
Rivaroxaban—CYP2J2—cardiac atrium—lung cancer	0.000841	0.0884	CbGeAlD
Rivaroxaban—F10—lung—lung cancer	0.000785	0.0825	CbGeAlD
Rivaroxaban—CYP2J2—lung—lung cancer	0.000643	0.0676	CbGeAlD
Rivaroxaban—F10—lymph node—lung cancer	0.000537	0.0564	CbGeAlD
Rivaroxaban—CYP3A5—respiratory system—lung cancer	0.000426	0.0448	CbGeAlD
Rivaroxaban—ABCB1—respiratory system—lung cancer	0.000226	0.0238	CbGeAlD
Rivaroxaban—CYP3A5—lung—lung cancer	0.000226	0.0238	CbGeAlD
Rivaroxaban—ABCB1—epithelium—lung cancer	0.000189	0.0199	CbGeAlD
Rivaroxaban—ABCB1—trachea—lung cancer	0.000167	0.0176	CbGeAlD
Rivaroxaban—ABCB1—bone marrow—lung cancer	0.000133	0.014	CbGeAlD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000126	0.000744	CcSEcCtD
Rivaroxaban—Nausea—Topotecan—lung cancer	0.000126	0.000741	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000125	0.000741	CcSEcCtD
Rivaroxaban—Discomfort—Paclitaxel—lung cancer	0.000125	0.00074	CcSEcCtD
Rivaroxaban—Fatigue—Gemcitabine—lung cancer	0.000125	0.00074	CcSEcCtD
Rivaroxaban—Pain—Gemcitabine—lung cancer	0.000124	0.000734	CcSEcCtD
Rivaroxaban—Constipation—Gemcitabine—lung cancer	0.000124	0.000734	CcSEcCtD
Rivaroxaban—Nausea—Erlotinib—lung cancer	0.000124	0.000734	CcSEcCtD
Rivaroxaban—Dry mouth—Paclitaxel—lung cancer	0.000124	0.000733	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Etoposide—lung cancer	0.000124	0.000732	CcSEcCtD
Rivaroxaban—Diarrhoea—Vinorelbine—lung cancer	0.000124	0.000731	CcSEcCtD
Rivaroxaban—Infection—Etoposide—lung cancer	0.000123	0.000728	CcSEcCtD
Rivaroxaban—Feeling abnormal—Irinotecan—lung cancer	0.000123	0.000726	CcSEcCtD
Rivaroxaban—Blood creatinine increased—Doxorubicin—lung cancer	0.000123	0.000724	CcSEcCtD
Rivaroxaban—Back pain—Docetaxel—lung cancer	0.000122	0.000721	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Irinotecan—lung cancer	0.000122	0.00072	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Paclitaxel—lung cancer	0.000122	0.000718	CcSEcCtD
Rivaroxaban—Oedema—Paclitaxel—lung cancer	0.000122	0.000718	CcSEcCtD
Rivaroxaban—Muscle spasms—Docetaxel—lung cancer	0.000121	0.000717	CcSEcCtD
Rivaroxaban—Tachycardia—Etoposide—lung cancer	0.000121	0.000715	CcSEcCtD
Rivaroxaban—Infection—Paclitaxel—lung cancer	0.000121	0.000713	CcSEcCtD
Rivaroxaban—Dyspnoea—Cisplatin—lung cancer	0.000121	0.000713	CcSEcCtD
Rivaroxaban—Skin disorder—Etoposide—lung cancer	0.00012	0.000711	CcSEcCtD
Rivaroxaban—ABCB1—lung—lung cancer	0.00012	0.0126	CbGeAlD
Rivaroxaban—Feeling abnormal—Gemcitabine—lung cancer	0.00012	0.000707	CcSEcCtD
Rivaroxaban—Shock—Paclitaxel—lung cancer	0.00012	0.000707	CcSEcCtD
Rivaroxaban—Dizziness—Vinorelbine—lung cancer	0.00012	0.000706	CcSEcCtD
Rivaroxaban—Abdominal pain upper—Doxorubicin—lung cancer	0.00012	0.000706	CcSEcCtD
Rivaroxaban—Nervous system disorder—Paclitaxel—lung cancer	0.000119	0.000704	CcSEcCtD
Rivaroxaban—Tachycardia—Paclitaxel—lung cancer	0.000119	0.000701	CcSEcCtD
Rivaroxaban—Skin disorder—Paclitaxel—lung cancer	0.000118	0.000698	CcSEcCtD
Rivaroxaban—Abdominal pain—Irinotecan—lung cancer	0.000118	0.000696	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Cisplatin—lung cancer	0.000117	0.00069	CcSEcCtD
Rivaroxaban—Anaemia—Docetaxel—lung cancer	0.000117	0.000689	CcSEcCtD
Rivaroxaban—Infestation NOS—Methotrexate—lung cancer	0.000116	0.000688	CcSEcCtD
Rivaroxaban—Infestation—Methotrexate—lung cancer	0.000116	0.000688	CcSEcCtD
Rivaroxaban—Hypotension—Etoposide—lung cancer	0.000116	0.000684	CcSEcCtD
Rivaroxaban—Pain—Cisplatin—lung cancer	0.000116	0.000684	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000115	0.000682	CcSEcCtD
Rivaroxaban—Vomiting—Vinorelbine—lung cancer	0.000115	0.000679	CcSEcCtD
Rivaroxaban—Renal failure—Methotrexate—lung cancer	0.000114	0.000676	CcSEcCtD
Rivaroxaban—Rash—Vinorelbine—lung cancer	0.000114	0.000673	CcSEcCtD
Rivaroxaban—Dermatitis—Vinorelbine—lung cancer	0.000114	0.000673	CcSEcCtD
Rivaroxaban—Hypotension—Paclitaxel—lung cancer	0.000114	0.000671	CcSEcCtD
Rivaroxaban—Headache—Vinorelbine—lung cancer	0.000113	0.000669	CcSEcCtD
Rivaroxaban—Syncope—Docetaxel—lung cancer	0.000113	0.000669	CcSEcCtD
Rivaroxaban—Feeling abnormal—Cisplatin—lung cancer	0.000112	0.000659	CcSEcCtD
Rivaroxaban—Haematuria—Methotrexate—lung cancer	0.000111	0.000656	CcSEcCtD
Rivaroxaban—Loss of consciousness—Docetaxel—lung cancer	0.000111	0.000656	CcSEcCtD
Rivaroxaban—Dyspnoea—Etoposide—lung cancer	0.000111	0.000653	CcSEcCtD
Rivaroxaban—Angina pectoris—Doxorubicin—lung cancer	0.00011	0.000651	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Methotrexate—lung cancer	0.00011	0.000651	CcSEcCtD
Rivaroxaban—Epistaxis—Methotrexate—lung cancer	0.00011	0.000649	CcSEcCtD
Rivaroxaban—Hypersensitivity—Irinotecan—lung cancer	0.00011	0.000649	CcSEcCtD
Rivaroxaban—Agranulocytosis—Methotrexate—lung cancer	0.000109	0.000642	CcSEcCtD
Rivaroxaban—Dyspnoea—Paclitaxel—lung cancer	0.000108	0.00064	CcSEcCtD
Rivaroxaban—Chest pain—Docetaxel—lung cancer	0.000108	0.000635	CcSEcCtD
Rivaroxaban—Nausea—Vinorelbine—lung cancer	0.000107	0.000634	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Etoposide—lung cancer	0.000107	0.000632	CcSEcCtD
Rivaroxaban—Dyspepsia—Paclitaxel—lung cancer	0.000107	0.000632	CcSEcCtD
Rivaroxaban—Asthenia—Irinotecan—lung cancer	0.000107	0.000632	CcSEcCtD
Rivaroxaban—Fatigue—Etoposide—lung cancer	0.000107	0.000631	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000107	0.000631	CcSEcCtD
Rivaroxaban—Pain—Etoposide—lung cancer	0.000106	0.000626	CcSEcCtD
Rivaroxaban—Constipation—Etoposide—lung cancer	0.000106	0.000626	CcSEcCtD
Rivaroxaban—Dry mouth—Docetaxel—lung cancer	0.000105	0.000621	CcSEcCtD
Rivaroxaban—Haemoglobin—Methotrexate—lung cancer	0.000105	0.000621	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000105	0.00062	CcSEcCtD
Rivaroxaban—Fatigue—Paclitaxel—lung cancer	0.000105	0.000619	CcSEcCtD
Rivaroxaban—Haemorrhage—Methotrexate—lung cancer	0.000105	0.000618	CcSEcCtD
Rivaroxaban—Hepatitis—Methotrexate—lung cancer	0.000105	0.000618	CcSEcCtD
Rivaroxaban—Asthenia—Gemcitabine—lung cancer	0.000104	0.000615	CcSEcCtD
Rivaroxaban—Pain—Paclitaxel—lung cancer	0.000104	0.000614	CcSEcCtD
Rivaroxaban—Constipation—Paclitaxel—lung cancer	0.000104	0.000614	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Methotrexate—lung cancer	0.000103	0.00061	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Docetaxel—lung cancer	0.000103	0.000609	CcSEcCtD
Rivaroxaban—Oedema—Docetaxel—lung cancer	0.000103	0.000609	CcSEcCtD
Rivaroxaban—Pruritus—Gemcitabine—lung cancer	0.000103	0.000607	CcSEcCtD
Rivaroxaban—Urethral disorder—Methotrexate—lung cancer	0.000102	0.000605	CcSEcCtD
Rivaroxaban—Infection—Docetaxel—lung cancer	0.000102	0.000605	CcSEcCtD
Rivaroxaban—Feeling abnormal—Etoposide—lung cancer	0.000102	0.000604	CcSEcCtD
Rivaroxaban—Diarrhoea—Irinotecan—lung cancer	0.000102	0.000603	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Etoposide—lung cancer	0.000101	0.000599	CcSEcCtD
Rivaroxaban—Shock—Docetaxel—lung cancer	0.000101	0.000599	CcSEcCtD
Rivaroxaban—Nervous system disorder—Docetaxel—lung cancer	0.000101	0.000597	CcSEcCtD
Rivaroxaban—Infestation NOS—Doxorubicin—lung cancer	0.000101	0.000596	CcSEcCtD
Rivaroxaban—Infestation—Doxorubicin—lung cancer	0.000101	0.000596	CcSEcCtD
Rivaroxaban—Tachycardia—Docetaxel—lung cancer	0.000101	0.000594	CcSEcCtD
Rivaroxaban—Feeling abnormal—Paclitaxel—lung cancer	0.0001	0.000592	CcSEcCtD
Rivaroxaban—Skin disorder—Docetaxel—lung cancer	0.0001	0.000591	CcSEcCtD
Rivaroxaban—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.0001	0.000591	CcSEcCtD
Rivaroxaban—Hypersensitivity—Cisplatin—lung cancer	9.97e-05	0.000589	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Paclitaxel—lung cancer	9.94e-05	0.000587	CcSEcCtD
Rivaroxaban—Diarrhoea—Gemcitabine—lung cancer	9.94e-05	0.000587	CcSEcCtD
Rivaroxaban—Renal failure—Doxorubicin—lung cancer	9.91e-05	0.000586	CcSEcCtD
Rivaroxaban—Erythema multiforme—Methotrexate—lung cancer	9.89e-05	0.000584	CcSEcCtD
Rivaroxaban—Dizziness—Irinotecan—lung cancer	9.86e-05	0.000582	CcSEcCtD
Rivaroxaban—Urticaria—Etoposide—lung cancer	9.85e-05	0.000582	CcSEcCtD
Rivaroxaban—Jaundice—Doxorubicin—lung cancer	9.83e-05	0.000581	CcSEcCtD
Rivaroxaban—Abdominal pain—Etoposide—lung cancer	9.8e-05	0.000579	CcSEcCtD
Rivaroxaban—Urinary tract infection—Doxorubicin—lung cancer	9.8e-05	0.000579	CcSEcCtD
Rivaroxaban—Eye disorder—Methotrexate—lung cancer	9.77e-05	0.000577	CcSEcCtD
Rivaroxaban—Asthenia—Cisplatin—lung cancer	9.71e-05	0.000574	CcSEcCtD
Rivaroxaban—Cardiac disorder—Methotrexate—lung cancer	9.7e-05	0.000573	CcSEcCtD
Rivaroxaban—Urticaria—Paclitaxel—lung cancer	9.66e-05	0.000571	CcSEcCtD
Rivaroxaban—Hypotension—Docetaxel—lung cancer	9.63e-05	0.000569	CcSEcCtD
Rivaroxaban—Haematuria—Doxorubicin—lung cancer	9.62e-05	0.000568	CcSEcCtD
Rivaroxaban—Abdominal pain—Paclitaxel—lung cancer	9.61e-05	0.000568	CcSEcCtD
Rivaroxaban—Hepatobiliary disease—Doxorubicin—lung cancer	9.54e-05	0.000563	CcSEcCtD
Rivaroxaban—Epistaxis—Doxorubicin—lung cancer	9.51e-05	0.000562	CcSEcCtD
Rivaroxaban—Angiopathy—Methotrexate—lung cancer	9.49e-05	0.00056	CcSEcCtD
Rivaroxaban—Vomiting—Irinotecan—lung cancer	9.48e-05	0.00056	CcSEcCtD
Rivaroxaban—Sinusitis—Doxorubicin—lung cancer	9.46e-05	0.000559	CcSEcCtD
Rivaroxaban—Immune system disorder—Methotrexate—lung cancer	9.44e-05	0.000558	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Methotrexate—lung cancer	9.42e-05	0.000557	CcSEcCtD
Rivaroxaban—Agranulocytosis—Doxorubicin—lung cancer	9.41e-05	0.000556	CcSEcCtD
Rivaroxaban—Rash—Irinotecan—lung cancer	9.4e-05	0.000555	CcSEcCtD
Rivaroxaban—Dermatitis—Irinotecan—lung cancer	9.39e-05	0.000555	CcSEcCtD
Rivaroxaban—Headache—Irinotecan—lung cancer	9.34e-05	0.000552	CcSEcCtD
Rivaroxaban—Diarrhoea—Cisplatin—lung cancer	9.26e-05	0.000547	CcSEcCtD
Rivaroxaban—Vomiting—Gemcitabine—lung cancer	9.23e-05	0.000545	CcSEcCtD
Rivaroxaban—Dyspnoea—Docetaxel—lung cancer	9.19e-05	0.000543	CcSEcCtD
Rivaroxaban—Rash—Gemcitabine—lung cancer	9.16e-05	0.000541	CcSEcCtD
Rivaroxaban—Dermatitis—Gemcitabine—lung cancer	9.15e-05	0.00054	CcSEcCtD
Rivaroxaban—Hypersensitivity—Etoposide—lung cancer	9.14e-05	0.00054	CcSEcCtD
Rivaroxaban—Haemoglobin—Doxorubicin—lung cancer	9.1e-05	0.000537	CcSEcCtD
Rivaroxaban—Headache—Gemcitabine—lung cancer	9.1e-05	0.000537	CcSEcCtD
Rivaroxaban—Dyspepsia—Docetaxel—lung cancer	9.07e-05	0.000536	CcSEcCtD
Rivaroxaban—Hepatitis—Doxorubicin—lung cancer	9.05e-05	0.000535	CcSEcCtD
Rivaroxaban—Haemorrhage—Doxorubicin—lung cancer	9.05e-05	0.000535	CcSEcCtD
Rivaroxaban—Hypersensitivity—Paclitaxel—lung cancer	8.96e-05	0.000529	CcSEcCtD
Rivaroxaban—Urinary tract disorder—Doxorubicin—lung cancer	8.94e-05	0.000528	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Docetaxel—lung cancer	8.9e-05	0.000526	CcSEcCtD
Rivaroxaban—Asthenia—Etoposide—lung cancer	8.9e-05	0.000526	CcSEcCtD
Rivaroxaban—Connective tissue disorder—Doxorubicin—lung cancer	8.9e-05	0.000525	CcSEcCtD
Rivaroxaban—Fatigue—Docetaxel—lung cancer	8.88e-05	0.000525	CcSEcCtD
Rivaroxaban—Urethral disorder—Doxorubicin—lung cancer	8.87e-05	0.000524	CcSEcCtD
Rivaroxaban—Nausea—Irinotecan—lung cancer	8.86e-05	0.000523	CcSEcCtD
Rivaroxaban—Pain—Docetaxel—lung cancer	8.81e-05	0.000521	CcSEcCtD
Rivaroxaban—Constipation—Docetaxel—lung cancer	8.81e-05	0.000521	CcSEcCtD
Rivaroxaban—Back pain—Methotrexate—lung cancer	8.8e-05	0.00052	CcSEcCtD
Rivaroxaban—Pruritus—Etoposide—lung cancer	8.77e-05	0.000518	CcSEcCtD
Rivaroxaban—Asthenia—Paclitaxel—lung cancer	8.72e-05	0.000515	CcSEcCtD
Rivaroxaban—Nausea—Gemcitabine—lung cancer	8.63e-05	0.00051	CcSEcCtD
Rivaroxaban—Vomiting—Cisplatin—lung cancer	8.61e-05	0.000508	CcSEcCtD
Rivaroxaban—Pruritus—Paclitaxel—lung cancer	8.6e-05	0.000508	CcSEcCtD
Rivaroxaban—Erythema multiforme—Doxorubicin—lung cancer	8.56e-05	0.000506	CcSEcCtD
Rivaroxaban—Rash—Cisplatin—lung cancer	8.53e-05	0.000504	CcSEcCtD
Rivaroxaban—Dermatitis—Cisplatin—lung cancer	8.53e-05	0.000504	CcSEcCtD
Rivaroxaban—Feeling abnormal—Docetaxel—lung cancer	8.49e-05	0.000502	CcSEcCtD
Rivaroxaban—Diarrhoea—Etoposide—lung cancer	8.48e-05	0.000501	CcSEcCtD
Rivaroxaban—Eye disorder—Doxorubicin—lung cancer	8.46e-05	0.0005	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Methotrexate—lung cancer	8.44e-05	0.000499	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Docetaxel—lung cancer	8.43e-05	0.000498	CcSEcCtD
Rivaroxaban—Anaemia—Methotrexate—lung cancer	8.41e-05	0.000497	CcSEcCtD
Rivaroxaban—Cardiac disorder—Doxorubicin—lung cancer	8.4e-05	0.000496	CcSEcCtD
Rivaroxaban—Diarrhoea—Paclitaxel—lung cancer	8.32e-05	0.000491	CcSEcCtD
Rivaroxaban—ABCB1—lymph node—lung cancer	8.22e-05	0.00865	CbGeAlD
Rivaroxaban—Angiopathy—Doxorubicin—lung cancer	8.21e-05	0.000485	CcSEcCtD
Rivaroxaban—Malaise—Methotrexate—lung cancer	8.21e-05	0.000485	CcSEcCtD
Rivaroxaban—Dizziness—Etoposide—lung cancer	8.2e-05	0.000484	CcSEcCtD
Rivaroxaban—Immune system disorder—Doxorubicin—lung cancer	8.18e-05	0.000483	CcSEcCtD
Rivaroxaban—Mediastinal disorder—Doxorubicin—lung cancer	8.16e-05	0.000482	CcSEcCtD
Rivaroxaban—Abdominal pain—Docetaxel—lung cancer	8.15e-05	0.000481	CcSEcCtD
Rivaroxaban—Dizziness—Paclitaxel—lung cancer	8.04e-05	0.000475	CcSEcCtD
Rivaroxaban—Nausea—Cisplatin—lung cancer	8.04e-05	0.000475	CcSEcCtD
Rivaroxaban—Vomiting—Etoposide—lung cancer	7.88e-05	0.000466	CcSEcCtD
Rivaroxaban—Rash—Etoposide—lung cancer	7.82e-05	0.000462	CcSEcCtD
Rivaroxaban—Dermatitis—Etoposide—lung cancer	7.81e-05	0.000461	CcSEcCtD
Rivaroxaban—Headache—Etoposide—lung cancer	7.77e-05	0.000459	CcSEcCtD
Rivaroxaban—Chest pain—Methotrexate—lung cancer	7.75e-05	0.000458	CcSEcCtD
Rivaroxaban—Vomiting—Paclitaxel—lung cancer	7.73e-05	0.000457	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.69e-05	0.000455	CcSEcCtD
Rivaroxaban—Rash—Paclitaxel—lung cancer	7.67e-05	0.000453	CcSEcCtD
Rivaroxaban—Dermatitis—Paclitaxel—lung cancer	7.66e-05	0.000452	CcSEcCtD
Rivaroxaban—Discomfort—Methotrexate—lung cancer	7.66e-05	0.000452	CcSEcCtD
Rivaroxaban—Back pain—Doxorubicin—lung cancer	7.62e-05	0.00045	CcSEcCtD
Rivaroxaban—Headache—Paclitaxel—lung cancer	7.62e-05	0.00045	CcSEcCtD
Rivaroxaban—Hypersensitivity—Docetaxel—lung cancer	7.59e-05	0.000448	CcSEcCtD
Rivaroxaban—Muscle spasms—Doxorubicin—lung cancer	7.58e-05	0.000448	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Methotrexate—lung cancer	7.43e-05	0.000439	CcSEcCtD
Rivaroxaban—Asthenia—Docetaxel—lung cancer	7.39e-05	0.000437	CcSEcCtD
Rivaroxaban—Infection—Methotrexate—lung cancer	7.38e-05	0.000436	CcSEcCtD
Rivaroxaban—Nausea—Etoposide—lung cancer	7.37e-05	0.000435	CcSEcCtD
Rivaroxaban—Ill-defined disorder—Doxorubicin—lung cancer	7.31e-05	0.000432	CcSEcCtD
Rivaroxaban—Pruritus—Docetaxel—lung cancer	7.29e-05	0.000431	CcSEcCtD
Rivaroxaban—Nervous system disorder—Methotrexate—lung cancer	7.28e-05	0.00043	CcSEcCtD
Rivaroxaban—Anaemia—Doxorubicin—lung cancer	7.28e-05	0.00043	CcSEcCtD
Rivaroxaban—Nausea—Paclitaxel—lung cancer	7.22e-05	0.000427	CcSEcCtD
Rivaroxaban—Skin disorder—Methotrexate—lung cancer	7.21e-05	0.000426	CcSEcCtD
Rivaroxaban—Malaise—Doxorubicin—lung cancer	7.11e-05	0.00042	CcSEcCtD
Rivaroxaban—Syncope—Doxorubicin—lung cancer	7.07e-05	0.000417	CcSEcCtD
Rivaroxaban—Diarrhoea—Docetaxel—lung cancer	7.05e-05	0.000416	CcSEcCtD
Rivaroxaban—Hypotension—Methotrexate—lung cancer	6.94e-05	0.00041	CcSEcCtD
Rivaroxaban—Loss of consciousness—Doxorubicin—lung cancer	6.93e-05	0.000409	CcSEcCtD
Rivaroxaban—Dizziness—Docetaxel—lung cancer	6.81e-05	0.000403	CcSEcCtD
Rivaroxaban—Chest pain—Doxorubicin—lung cancer	6.71e-05	0.000396	CcSEcCtD
Rivaroxaban—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.66e-05	0.000394	CcSEcCtD
Rivaroxaban—Discomfort—Doxorubicin—lung cancer	6.63e-05	0.000392	CcSEcCtD
Rivaroxaban—Dyspnoea—Methotrexate—lung cancer	6.62e-05	0.000391	CcSEcCtD
Rivaroxaban—Dry mouth—Doxorubicin—lung cancer	6.56e-05	0.000388	CcSEcCtD
Rivaroxaban—Vomiting—Docetaxel—lung cancer	6.55e-05	0.000387	CcSEcCtD
Rivaroxaban—Dyspepsia—Methotrexate—lung cancer	6.54e-05	0.000386	CcSEcCtD
Rivaroxaban—Rash—Docetaxel—lung cancer	6.5e-05	0.000384	CcSEcCtD
Rivaroxaban—Dermatitis—Docetaxel—lung cancer	6.49e-05	0.000383	CcSEcCtD
Rivaroxaban—Headache—Docetaxel—lung cancer	6.46e-05	0.000381	CcSEcCtD
Rivaroxaban—Oedema—Doxorubicin—lung cancer	6.43e-05	0.00038	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Doxorubicin—lung cancer	6.43e-05	0.00038	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Methotrexate—lung cancer	6.41e-05	0.000379	CcSEcCtD
Rivaroxaban—Fatigue—Methotrexate—lung cancer	6.4e-05	0.000378	CcSEcCtD
Rivaroxaban—Infection—Doxorubicin—lung cancer	6.39e-05	0.000377	CcSEcCtD
Rivaroxaban—Pain—Methotrexate—lung cancer	6.35e-05	0.000375	CcSEcCtD
Rivaroxaban—Shock—Doxorubicin—lung cancer	6.33e-05	0.000374	CcSEcCtD
Rivaroxaban—Nervous system disorder—Doxorubicin—lung cancer	6.31e-05	0.000373	CcSEcCtD
Rivaroxaban—Tachycardia—Doxorubicin—lung cancer	6.28e-05	0.000371	CcSEcCtD
Rivaroxaban—Skin disorder—Doxorubicin—lung cancer	6.25e-05	0.000369	CcSEcCtD
Rivaroxaban—Nausea—Docetaxel—lung cancer	6.12e-05	0.000362	CcSEcCtD
Rivaroxaban—Feeling abnormal—Methotrexate—lung cancer	6.12e-05	0.000362	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Methotrexate—lung cancer	6.07e-05	0.000359	CcSEcCtD
Rivaroxaban—Hypotension—Doxorubicin—lung cancer	6.01e-05	0.000355	CcSEcCtD
Rivaroxaban—Urticaria—Methotrexate—lung cancer	5.9e-05	0.000349	CcSEcCtD
Rivaroxaban—Abdominal pain—Methotrexate—lung cancer	5.87e-05	0.000347	CcSEcCtD
Rivaroxaban—Dyspnoea—Doxorubicin—lung cancer	5.73e-05	0.000339	CcSEcCtD
Rivaroxaban—Dyspepsia—Doxorubicin—lung cancer	5.66e-05	0.000334	CcSEcCtD
Rivaroxaban—Gastrointestinal disorder—Doxorubicin—lung cancer	5.55e-05	0.000328	CcSEcCtD
Rivaroxaban—Fatigue—Doxorubicin—lung cancer	5.55e-05	0.000328	CcSEcCtD
Rivaroxaban—Pain—Doxorubicin—lung cancer	5.5e-05	0.000325	CcSEcCtD
Rivaroxaban—Constipation—Doxorubicin—lung cancer	5.5e-05	0.000325	CcSEcCtD
Rivaroxaban—Hypersensitivity—Methotrexate—lung cancer	5.47e-05	0.000323	CcSEcCtD
Rivaroxaban—Asthenia—Methotrexate—lung cancer	5.33e-05	0.000315	CcSEcCtD
Rivaroxaban—Feeling abnormal—Doxorubicin—lung cancer	5.3e-05	0.000313	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Doxorubicin—lung cancer	5.26e-05	0.000311	CcSEcCtD
Rivaroxaban—Pruritus—Methotrexate—lung cancer	5.26e-05	0.00031	CcSEcCtD
Rivaroxaban—Urticaria—Doxorubicin—lung cancer	5.11e-05	0.000302	CcSEcCtD
Rivaroxaban—Abdominal pain—Doxorubicin—lung cancer	5.08e-05	0.0003	CcSEcCtD
Rivaroxaban—Diarrhoea—Methotrexate—lung cancer	5.08e-05	0.0003	CcSEcCtD
Rivaroxaban—Dizziness—Methotrexate—lung cancer	4.91e-05	0.00029	CcSEcCtD
Rivaroxaban—Hypersensitivity—Doxorubicin—lung cancer	4.74e-05	0.00028	CcSEcCtD
Rivaroxaban—Vomiting—Methotrexate—lung cancer	4.72e-05	0.000279	CcSEcCtD
Rivaroxaban—Rash—Methotrexate—lung cancer	4.68e-05	0.000277	CcSEcCtD
Rivaroxaban—Dermatitis—Methotrexate—lung cancer	4.68e-05	0.000276	CcSEcCtD
Rivaroxaban—Headache—Methotrexate—lung cancer	4.65e-05	0.000275	CcSEcCtD
Rivaroxaban—Asthenia—Doxorubicin—lung cancer	4.61e-05	0.000273	CcSEcCtD
Rivaroxaban—Pruritus—Doxorubicin—lung cancer	4.55e-05	0.000269	CcSEcCtD
Rivaroxaban—Nausea—Methotrexate—lung cancer	4.41e-05	0.000261	CcSEcCtD
Rivaroxaban—Diarrhoea—Doxorubicin—lung cancer	4.4e-05	0.00026	CcSEcCtD
Rivaroxaban—Dizziness—Doxorubicin—lung cancer	4.25e-05	0.000251	CcSEcCtD
Rivaroxaban—Vomiting—Doxorubicin—lung cancer	4.09e-05	0.000242	CcSEcCtD
Rivaroxaban—Rash—Doxorubicin—lung cancer	4.06e-05	0.00024	CcSEcCtD
Rivaroxaban—Dermatitis—Doxorubicin—lung cancer	4.05e-05	0.000239	CcSEcCtD
Rivaroxaban—CYP3A4—Biological oxidations—GSTT1—lung cancer	4.04e-05	0.000461	CbGpPWpGaD
Rivaroxaban—Headache—Doxorubicin—lung cancer	4.03e-05	0.000238	CcSEcCtD
Rivaroxaban—CYP3A4—Biological oxidations—GCLC—lung cancer	4e-05	0.000455	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2A6—lung cancer	4e-05	0.000455	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—VEGFA—lung cancer	3.99e-05	0.000455	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ATP5H—lung cancer	3.93e-05	0.000447	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—POMC—lung cancer	3.92e-05	0.000446	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	3.89e-05	0.000443	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—STK11—lung cancer	3.87e-05	0.00044	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—EP300—lung cancer	3.86e-05	0.00044	CbGpPWpGaD
Rivaroxaban—Nausea—Doxorubicin—lung cancer	3.82e-05	0.000226	CcSEcCtD
Rivaroxaban—F10—Hemostasis—SRC—lung cancer	3.76e-05	0.000428	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—VEGFA—lung cancer	3.66e-05	0.000417	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3.63e-05	0.000413	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NRAS—lung cancer	3.61e-05	0.000411	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTP1—lung cancer	3.58e-05	0.000407	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	3.57e-05	0.000407	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—lung cancer	3.54e-05	0.000403	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLBD1—lung cancer	3.5e-05	0.000399	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AZIN2—lung cancer	3.49e-05	0.000397	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—COL4A3BP—lung cancer	3.49e-05	0.000397	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CAT—lung cancer	3.48e-05	0.000396	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—EP300—lung cancer	3.46e-05	0.000394	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—MAPK3—lung cancer	3.46e-05	0.000394	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—VEGFA—lung cancer	3.46e-05	0.000394	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	3.43e-05	0.00039	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP2E1—lung cancer	3.4e-05	0.000387	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ABCB1—lung cancer	3.39e-05	0.000386	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	3.35e-05	0.000382	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—TYMS—lung cancer	3.33e-05	0.000379	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	3.29e-05	0.000375	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GSTM1—lung cancer	3.29e-05	0.000374	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HSD17B10—lung cancer	3.2e-05	0.000365	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CYP1A1—lung cancer	3.12e-05	0.000355	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KRAS—lung cancer	3.11e-05	0.000354	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ERCC2—lung cancer	3.09e-05	0.000352	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCC3—lung cancer	3.09e-05	0.000352	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CKB—lung cancer	2.98e-05	0.000339	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ATP5H—lung cancer	2.96e-05	0.000338	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PIK3CA—lung cancer	2.86e-05	0.000325	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—APC—lung cancer	2.85e-05	0.000325	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	2.82e-05	0.000321	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTP1—lung cancer	2.8e-05	0.000319	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—GNG11—lung cancer	2.8e-05	0.000319	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM2—lung cancer	2.8e-05	0.000319	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CNDP2—lung cancer	2.8e-05	0.000319	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	2.76e-05	0.000315	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TP53—lung cancer	2.76e-05	0.000315	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—MTMR3—lung cancer	2.72e-05	0.00031	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—APOA1—lung cancer	2.67e-05	0.000305	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	2.66e-05	0.000303	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PGAM1—lung cancer	2.65e-05	0.000302	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	2.65e-05	0.000301	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HRAS—lung cancer	2.64e-05	0.000301	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLBD1—lung cancer	2.64e-05	0.000301	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.58e-05	0.000293	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.56e-05	0.000292	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—AKT1—lung cancer	2.55e-05	0.00029	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.54e-05	0.000289	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2A7—lung cancer	2.53e-05	0.000288	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	2.53e-05	0.000288	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ADCY1—lung cancer	2.52e-05	0.000287	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ABCG2—lung cancer	2.52e-05	0.000287	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—SDC4—lung cancer	2.48e-05	0.000282	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.44e-05	0.000278	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CG—lung cancer	2.44e-05	0.000278	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HSD17B10—lung cancer	2.42e-05	0.000275	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.41e-05	0.000274	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TF—lung cancer	2.34e-05	0.000267	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—AKT1—lung cancer	2.33e-05	0.000266	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—POMC—lung cancer	2.32e-05	0.000265	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CREBBP—lung cancer	2.26e-05	0.000258	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—RRM1—lung cancer	2.26e-05	0.000257	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA3—lung cancer	2.26e-05	0.000257	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	2.25e-05	0.000256	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CKB—lung cancer	2.25e-05	0.000256	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	2.24e-05	0.000255	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	2.22e-05	0.000252	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	2.17e-05	0.000247	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.15e-05	0.000245	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AZIN2—lung cancer	2.15e-05	0.000245	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CD—lung cancer	2.15e-05	0.000244	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—B4GALT5—lung cancer	2.12e-05	0.000242	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—lung cancer	2.12e-05	0.000241	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CNDP2—lung cancer	2.11e-05	0.000241	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM2—lung cancer	2.11e-05	0.000241	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA4—lung cancer	2.06e-05	0.000235	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—MTMR3—lung cancer	2.05e-05	0.000234	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	2.01e-05	0.000229	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA2—lung cancer	2.01e-05	0.000229	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PGAM1—lung cancer	2e-05	0.000228	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	1.96e-05	0.000223	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	1.95e-05	0.000223	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTA1—lung cancer	1.94e-05	0.000221	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCC3—lung cancer	1.92e-05	0.000219	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2A7—lung cancer	1.91e-05	0.000218	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	1.89e-05	0.000216	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	1.89e-05	0.000215	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CB—lung cancer	1.87e-05	0.000213	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—SDC4—lung cancer	1.87e-05	0.000213	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKR1C1—lung cancer	1.86e-05	0.000212	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—lung cancer	1.85e-05	0.000211	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ATP5H—lung cancer	1.83e-05	0.000208	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—POMC—lung cancer	1.82e-05	0.000207	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—UGT1A1—lung cancer	1.8e-05	0.000205	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	1.8e-05	0.000205	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	1.75e-05	0.0002	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GNG11—lung cancer	1.74e-05	0.000198	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	1.71e-05	0.000194	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA3—lung cancer	1.7e-05	0.000194	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—RRM1—lung cancer	1.7e-05	0.000194	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDOA—lung cancer	1.66e-05	0.000189	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLBD1—lung cancer	1.63e-05	0.000185	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	1.62e-05	0.000185	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTEN—lung cancer	1.62e-05	0.000184	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	1.62e-05	0.000184	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NCOA3—lung cancer	1.61e-05	0.000183	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—B4GALT5—lung cancer	1.6e-05	0.000182	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	1.57e-05	0.000179	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCG2—lung cancer	1.56e-05	0.000178	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADCY1—lung cancer	1.56e-05	0.000178	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA4—lung cancer	1.56e-05	0.000177	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—EP300—lung cancer	1.54e-05	0.000176	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	1.54e-05	0.000175	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—HPGDS—lung cancer	1.53e-05	0.000175	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ENO2—lung cancer	1.53e-05	0.000175	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPP2R1B—lung cancer	1.52e-05	0.000174	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA2—lung cancer	1.52e-05	0.000173	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HSD17B10—lung cancer	1.49e-05	0.00017	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTT1—lung cancer	1.49e-05	0.000169	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCLC—lung cancer	1.47e-05	0.000167	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2A6—lung cancer	1.47e-05	0.000167	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTA1—lung cancer	1.46e-05	0.000167	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.45e-05	0.000165	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCC3—lung cancer	1.45e-05	0.000165	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKR1C1—lung cancer	1.4e-05	0.00016	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ENO1—lung cancer	1.39e-05	0.000159	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CKB—lung cancer	1.38e-05	0.000158	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—UGT1A1—lung cancer	1.36e-05	0.000155	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.33e-05	0.000152	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GNG11—lung cancer	1.31e-05	0.000149	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CNDP2—lung cancer	1.3e-05	0.000148	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM2—lung cancer	1.3e-05	0.000148	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.29e-05	0.000147	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—MTMR3—lung cancer	1.27e-05	0.000144	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP2E1—lung cancer	1.25e-05	0.000142	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDOA—lung cancer	1.25e-05	0.000142	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.24e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—NQO1—lung cancer	1.24e-05	0.000141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PGAM1—lung cancer	1.23e-05	0.000141	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NCOA3—lung cancer	1.21e-05	0.000138	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ABCG2—lung cancer	1.18e-05	0.000134	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADCY1—lung cancer	1.18e-05	0.000134	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2A7—lung cancer	1.18e-05	0.000134	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—HPGDS—lung cancer	1.16e-05	0.000132	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ENO2—lung cancer	1.16e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—SDC4—lung cancer	1.15e-05	0.000131	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPP2R1B—lung cancer	1.15e-05	0.000131	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PIK3CA—lung cancer	1.14e-05	0.00013	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTT1—lung cancer	1.12e-05	0.000128	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—STK11—lung cancer	1.11e-05	0.000127	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCLC—lung cancer	1.11e-05	0.000126	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2A6—lung cancer	1.11e-05	0.000126	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.09e-05	0.000124	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ENO1—lung cancer	1.05e-05	0.00012	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.05e-05	0.00012	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—RRM1—lung cancer	1.05e-05	0.000119	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA3—lung cancer	1.05e-05	0.000119	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTP1—lung cancer	1.03e-05	0.000117	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CAT—lung cancer	1e-05	0.000114	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—B4GALT5—lung cancer	9.86e-06	0.000112	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	9.84e-06	0.000112	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ABCB1—lung cancer	9.76e-06	0.000111	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA4—lung cancer	9.59e-06	0.000109	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—TYMS—lung cancer	9.59e-06	0.000109	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GSTM1—lung cancer	9.47e-06	0.000108	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP2E1—lung cancer	9.43e-06	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA2—lung cancer	9.35e-06	0.000106	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—NQO1—lung cancer	9.33e-06	0.000106	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—AKT1—lung cancer	9.31e-06	0.000106	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTA1—lung cancer	9.02e-06	0.000103	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CYP1A1—lung cancer	8.98e-06	0.000102	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCC3—lung cancer	8.92e-06	0.000102	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ERCC2—lung cancer	8.91e-06	0.000101	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	8.9e-06	0.000101	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKR1C1—lung cancer	8.64e-06	9.84e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—STK11—lung cancer	8.41e-06	9.58e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—UGT1A1—lung cancer	8.39e-06	9.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GNG11—lung cancer	8.09e-06	9.21e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTP1—lung cancer	7.78e-06	8.86e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—APOA1—lung cancer	7.71e-06	8.78e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDOA—lung cancer	7.7e-06	8.77e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CAT—lung cancer	7.57e-06	8.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NCOA3—lung cancer	7.47e-06	8.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADCY1—lung cancer	7.27e-06	8.28e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCG2—lung cancer	7.27e-06	8.28e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—TYMS—lung cancer	7.23e-06	8.24e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GSTM1—lung cancer	7.15e-06	8.14e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—HPGDS—lung cancer	7.13e-06	8.12e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENO2—lung cancer	7.13e-06	8.12e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.09e-06	8.07e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CG—lung cancer	7.04e-06	8.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTT1—lung cancer	6.92e-06	7.88e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCLC—lung cancer	6.84e-06	7.79e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2A6—lung cancer	6.84e-06	7.79e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CYP1A1—lung cancer	6.78e-06	7.72e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ERCC2—lung cancer	6.72e-06	7.66e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—POMC—lung cancer	6.7e-06	7.63e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CREBBP—lung cancer	6.52e-06	7.43e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ENO1—lung cancer	6.48e-06	7.38e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CD—lung cancer	6.18e-06	7.04e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—lung cancer	6.11e-06	6.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—APOA1—lung cancer	5.82e-06	6.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP2E1—lung cancer	5.81e-06	6.62e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—NQO1—lung cancer	5.75e-06	6.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CB—lung cancer	5.39e-06	6.14e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—lung cancer	5.34e-06	6.08e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CG—lung cancer	5.31e-06	6.05e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—STK11—lung cancer	5.18e-06	5.9e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—POMC—lung cancer	5.05e-06	5.76e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CREBBP—lung cancer	4.92e-06	5.61e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTP1—lung cancer	4.79e-06	5.46e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CD—lung cancer	4.67e-06	5.32e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CAT—lung cancer	4.66e-06	5.31e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTEN—lung cancer	4.66e-06	5.31e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—lung cancer	4.61e-06	5.25e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ABCB1—lung cancer	4.54e-06	5.17e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—TYMS—lung cancer	4.46e-06	5.08e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—EP300—lung cancer	4.44e-06	5.06e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GSTM1—lung cancer	4.4e-06	5.02e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CYP1A1—lung cancer	4.18e-06	4.76e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ERCC2—lung cancer	4.14e-06	4.72e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CB—lung cancer	4.07e-06	4.63e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—lung cancer	4.03e-06	4.59e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—APOA1—lung cancer	3.58e-06	4.08e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTEN—lung cancer	3.52e-06	4e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—EP300—lung cancer	3.35e-06	3.82e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PIK3CA—lung cancer	3.29e-06	3.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CG—lung cancer	3.27e-06	3.73e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—POMC—lung cancer	3.11e-06	3.55e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CREBBP—lung cancer	3.03e-06	3.45e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CD—lung cancer	2.88e-06	3.27e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—lung cancer	2.84e-06	3.23e-05	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—AKT1—lung cancer	2.68e-06	3.06e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CB—lung cancer	2.51e-06	2.85e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—lung cancer	2.48e-06	2.83e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PIK3CA—lung cancer	2.48e-06	2.82e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTEN—lung cancer	2.17e-06	2.47e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—EP300—lung cancer	2.07e-06	2.35e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—AKT1—lung cancer	2.03e-06	2.31e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PIK3CA—lung cancer	1.53e-06	1.74e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—AKT1—lung cancer	1.25e-06	1.42e-05	CbGpPWpGaD
